Cargando…
Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
Autor principal: | Lapeyre-Mestre, Maryse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933181/ https://www.ncbi.nlm.nih.gov/pubmed/31891147 http://dx.doi.org/10.1016/j.eclinm.2019.11.009 |
Ejemplares similares
-
Adverse reaction signal detection methodology in pharmacoepidemiology
por: Stricker, Bruno H.
Publicado: (2018) -
Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008) -
Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
por: Noguchi, Yoshihiro, et al.
Publicado: (2023) -
Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
por: Berthet, Stephanie, et al.
Publicado: (2011) -
Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study
por: Glamočlija, Una, et al.
Publicado: (2018)